Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym

Clinical trial NCT06760156 · RECRUITING

Trial details

NCT number: NCT06760156
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Large B-cell Lymphoma

Start date: 2025-03-19
Primary completion: 2027-01-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.